How Janssen is Collaboratively Working with Patients and Sites to Advance DCTs
In this session, Janssen shares how they are collaboratively working with patients and sites to advance DCTs and will share engagement methodologies, what they have learned from the perspective of pa...
5 Jan 202318min
How Merck is Partnering with Communities to Support Clinical Research
Merck’s iLab53 (a modular 39-foot mobile unit) was used to bring clinical research into community settings as an effort to increase clinical trial awareness and engagement. More specifically: How th...
4 Jan 202321min
Sanofi’s New Initiatives Firmly Embedding Patient Experience & Perspectives
In this session, Sanofi shares how they created and implemented an end-to-end fully integrated patient informed R&D organization that works directly with patients as advisors in 100% of development s...
3 Jan 202321min
Reflections on Alnylam and Conquering Delivery
In this podcast, you will hear a keynote presentation from Dr John Maraganore from the 2022 PODD Conference regarding lessons learned from his 19 years as CEO of Alnylam Pharmaceuticals, leading a tea...
3 Jan 202331min
Patient Involvement Legal Barriers to Be Aware of and Pathways to Overcome Them
Legal barriers exist for many good reasons, but can block our pathway in making the changes needed to help patients in the current climate. The panel addresses: Protocols that require approval from le...
2 Jan 202342min
Next Generation Immune Checkpoints: Deciphering Key Roles in the TME
Learn more about the IO360° Summit at www.io360summit.com
2 Jan 202315min
Merck Reporting on Site Monitoring, Performance and Database Lock
In this session recorded at DPHARM 2021, Merck shares about their proprietary Site Monitoring and Reporting Tool (SMART), an iOS Apple iPad technology that enables “monitoring and deviation management...
31 Des 202247min
The Role of RWD in the Development of Remdesivir
In this session from DPHARM 2021, Gilead shares how they designed, developed and obtained Emergency Use Authorization and Full Approval for Remdesivir for the treatment of COVID-19 in record time. Ke...
30 Des 202241min
